Table 4.
Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | |
Age >65 years | 1.85 | 0.33–10.35 | 0.488 | 1.04 | 0.16–6.71 | 0.968 |
Male gender | 1.04 | 0.28–3.86 | 0.947 | 3.82 | 0.96–15.20 | 0.086 |
Node-positive primary disease | 0.15 | 0.04–0.59 | 0.014 | 0.61 | 0.09–4.02 | 0.615 |
Disease-free interval <12 months | 0.37 | 0.09–1.50 | 0.175 | 0.58 | 0.12–2.88 | 0.522 |
CEA >200 ng/ml | 0.45 | 0.05–3.88 | 0.476 | 0.12 | 0.01–1.39 | 0.120 |
More than three lesions | 1.17 | 0.28–4.90 | 0.831 | 0.31 | 0.07–1.40 | 0.158 |
Extrahepatic metastases | 0.24 | 0.08–0.76 | 0.021 | 0.12 | 0.02–0.62 | 0.030 |
Interval between surgeries >150 days | 1.21 | 0.30–4.86 | 0.787 |
OR, odds ratio; 95% CI, 95% confidence interval; CEA, carcinoembryonic antigen.